Header Logo

Connection

MICHAEL FRUMOVITZ to Female

Back to Details
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Female.
MICHAEL FRUMOVITZ
Connection Strength
1.666
Female
  1. Neuroendocrine neoplasms of the ovary: a review of 63 cases. Int J Gynecol Cancer. 2024 Apr 01; 34(4):566-573.
    View in: PubMed
    Score: 0.026
  2. PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study. Int J Gynecol Cancer. 2023 11 06; 33(11):1690-1694.
    View in: PubMed
    Score: 0.025
  3. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer. 2023 09 04; 33(9):1359-1369.
    View in: PubMed
    Score: 0.025
  4. Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. Oncologist. 2023 07 05; 28(7):618-623.
    View in: PubMed
    Score: 0.025
  5. Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer. Obstet Gynecol. 2023 05 01; 141(5):1019-1023.
    View in: PubMed
    Score: 0.024
  6. Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix. Int J Gynecol Cancer. 2023 04 03; 33(4):623-627.
    View in: PubMed
    Score: 0.024
  7. Open radical hysterectomy: The new standard of care in early-stage cervical cancer. BJOG. 2023 07; 130(8):851-855.
    View in: PubMed
    Score: 0.024
  8. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol Oncol. 2023 03; 170:328-332.
    View in: PubMed
    Score: 0.024
  9. RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study. J Gynecol Oncol. 2023 07; 34(4):e50.
    View in: PubMed
    Score: 0.024
  10. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study. Am J Obstet Gynecol. 2023 04; 228(4):445.e1-445.e8.
    View in: PubMed
    Score: 0.024
  11. Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2022 11 07; 32(11):1469-1474.
    View in: PubMed
    Score: 0.024
  12. Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study. Gynecol Oncol. 2022 06; 165(3):530-537.
    View in: PubMed
    Score: 0.023
  13. Early-stage, high-grade neuroendocrine cervical carcinoma. Int J Gynecol Cancer. 2021 08; 31(8):1179-1183.
    View in: PubMed
    Score: 0.022
  14. Surgical staging, the meaning of life, and other existential ponderings. Int J Gynecol Cancer. 2020 12; 30(12):1862-1863.
    View in: PubMed
    Score: 0.021
  15. Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix. Int J Gynecol Cancer. 2020 09; 30(9):1303-1307.
    View in: PubMed
    Score: 0.020
  16. Comparative genomics of high grade neuroendocrine carcinoma of the cervix. PLoS One. 2020; 15(6):e0234505.
    View in: PubMed
    Score: 0.020
  17. Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol. 2020 09; 158(3):570-575.
    View in: PubMed
    Score: 0.020
  18. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020 06; 21(6):851-860.
    View in: PubMed
    Score: 0.020
  19. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
    View in: PubMed
    Score: 0.020
  20. Encouraging worldwide adoption of sentinel lymph node biopsies for gynecologic malignancies. Int J Gynecol Cancer. 2020 03; 30(3):281-282.
    View in: PubMed
    Score: 0.020
  21. International Gynecologic Cancer Society 2019 meeting summary. Int J Gynecol Cancer. 2020 02; 30(2):167-173.
    View in: PubMed
    Score: 0.019
  22. Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 12; 134(6):1253-1259.
    View in: PubMed
    Score: 0.019
  23. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer. 2019 07; 29(6):986-995.
    View in: PubMed
    Score: 0.019
  24. Reproductive counseling and pregnancy outcomes after radical trachelectomy for early stage cervical cancer. J Gynecol Oncol. 2019 May; 30(3):e45.
    View in: PubMed
    Score: 0.018
  25. Tailoring adjuvant treatment in patients with uterine cancer - Authors' reply. Lancet Oncol. 2018 12; 19(12):e656.
    View in: PubMed
    Score: 0.018
  26. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol. 2018 10; 19(10):1394-1403.
    View in: PubMed
    Score: 0.018
  27. Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type. J Minim Invasive Gynecol. 2019 01; 26(1):87-93.
    View in: PubMed
    Score: 0.017
  28. Radical Hysterectomy and Age: Outcomes Comparison Based on a Minimally Invasive vs an Open Approach. J Minim Invasive Gynecol. 2018 Nov - Dec; 25(7):1224-1230.
    View in: PubMed
    Score: 0.017
  29. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
    View in: PubMed
    Score: 0.016
  30. Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take? Gynecol Oncol. 2017 01; 144(1):3-4.
    View in: PubMed
    Score: 0.016
  31. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Gynecol Oncol. 2017 Jan; 144(1):46-50.
    View in: PubMed
    Score: 0.016
  32. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557.
    View in: PubMed
    Score: 0.015
  33. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer. Gynecol Oncol. 2016 08; 142(2):283-5.
    View in: PubMed
    Score: 0.015
  34. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol Oncol. 2016 06; 141(3):588-591.
    View in: PubMed
    Score: 0.015
  35. Small- and Large-Cell Neuroendocrine Cervical Cancer. Oncology (Williston Park). 2016 Jan; 30(1):70, 77-8, 93.
    View in: PubMed
    Score: 0.015
  36. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther. 2015; 15(7):805-10.
    View in: PubMed
    Score: 0.014
  37. Optimizing sentinel node identification: a step toward novel tools and improved strategies--exciting times are here! J Minim Invasive Gynecol. 2015 Feb; 22(2):153-4.
    View in: PubMed
    Score: 0.014
  38. Sentinel nodes in cervical cancer: surgical innovation outside the ivory towers. Ann Surg Oncol. 2015 Jun; 22(6):1759-60.
    View in: PubMed
    Score: 0.014
  39. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-1104.
    View in: PubMed
    Score: 0.014
  40. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia. Gynecol Oncol. 2014 Dec; 135(3):451-4.
    View in: PubMed
    Score: 0.013
  41. Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go? J Minim Invasive Gynecol. 2015 Feb; 22(2):185-92.
    View in: PubMed
    Score: 0.013
  42. Physician pain and discomfort during minimally invasive gynecologic cancer surgery. Gynecol Oncol. 2014 Aug; 134(2):243-7.
    View in: PubMed
    Score: 0.013
  43. Mucinous tumors of the ovary: current thoughts on diagnosis and management. Curr Oncol Rep. 2014 Jun; 16(6):389.
    View in: PubMed
    Score: 0.013
  44. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5.
    View in: PubMed
    Score: 0.013
  45. A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):275-9.
    View in: PubMed
    Score: 0.013
  46. Successful laparoscopic removal of adnexal mass in a patient with a large ventral hernia. J Minim Invasive Gynecol. 2014 May-Jun; 21(3):325-6.
    View in: PubMed
    Score: 0.013
  47. Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53.
    View in: PubMed
    Score: 0.013
  48. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014 Jan-Feb; 21(1):3-8.
    View in: PubMed
    Score: 0.012
  49. Laparoscopic hysterectomy for endometrial cancer: an established benefit no longer in question. J Minim Invasive Gynecol. 2013 Jul-Aug; 20(4):401-3.
    View in: PubMed
    Score: 0.012
  50. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7.
    View in: PubMed
    Score: 0.012
  51. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.
    View in: PubMed
    Score: 0.012
  52. Utility of conization with frozen section for intraoperative triage prior to definitive hysterectomy. Gynecol Oncol. 2012 Nov; 127(2):307-11.
    View in: PubMed
    Score: 0.012
  53. Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol. 2012 Sep; 126(3):351-6.
    View in: PubMed
    Score: 0.011
  54. Minimally invasive surgical approaches for patients with endometrial cancer. Clin Obstet Gynecol. 2011 Jun; 54(2):226-34.
    View in: PubMed
    Score: 0.011
  55. Balancing fertility and oncologic outcomes: can we have our cake and eat it too? Ann Surg Oncol. 2011 Jan; 18(1):10-1.
    View in: PubMed
    Score: 0.010
  56. Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. Int J Gynecol Cancer. 2011 Jan; 21(1):123-7.
    View in: PubMed
    Score: 0.010
  57. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010 Dec; 116(6):1358-1365.
    View in: PubMed
    Score: 0.010
  58. Laparoscopic total hysterectomy vs supracervical hysterectomy: turn, turn, turn. J Minim Invasive Gynecol. 2010 Nov-Dec; 17(6):669-70.
    View in: PubMed
    Score: 0.010
  59. Unmasking the complexities of mucinous ovarian carcinoma. Gynecol Oncol. 2010 Jun; 117(3):491-6.
    View in: PubMed
    Score: 0.010
  60. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-99.
    View in: PubMed
    Score: 0.009
  61. Gallbladder carcinoma presenting as a pelvic mass with elevated serum testosterone: a case report. J Reprod Med. 2009 Apr; 54(4):259-60.
    View in: PubMed
    Score: 0.009
  62. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct; 112(4):899-905.
    View in: PubMed
    Score: 0.009
  63. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol. 2008 Nov; 111(2):197-201.
    View in: PubMed
    Score: 0.009
  64. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S17-20.
    View in: PubMed
    Score: 0.009
  65. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S25-8.
    View in: PubMed
    Score: 0.009
  66. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S21-4.
    View in: PubMed
    Score: 0.009
  67. Is lymphatic mapping in uterine cancer feasible? Ann Surg Oncol. 2008 Jul; 15(7):1815-7.
    View in: PubMed
    Score: 0.009
  68. Lymphatic mapping and sentinel node biopsy in vulvar, vaginal, and cervical cancers. Oncology (Williston Park). 2008 Apr 30; 22(5):529-36; discussion 538-9, 542-3.
    View in: PubMed
    Score: 0.009
  69. Puntambekar et Al. Laparoscopic total radical hysterectomy by the Pune technique: our experience of 248 cases. J Minim Invasive Gynecol. 2008 Mar-Apr; 15(2):254-5; author reply 255.
    View in: PubMed
    Score: 0.009
  70. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008 Mar; 108(3):478-81.
    View in: PubMed
    Score: 0.008
  71. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol. 2007 Jul; 110(1):96-102.
    View in: PubMed
    Score: 0.008
  72. Laparoscopic extraperitoneal para-aortic lymphadenectomy. Gynecol Oncol. 2007 Aug; 106(2):433-4; author reply 435.
    View in: PubMed
    Score: 0.008
  73. Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies. Gynecol Oncol. 2007 Mar; 104(3):768-78.
    View in: PubMed
    Score: 0.008
  74. Total laparoscopic radical hysterectomy: surgical technique and instrumentation. Gynecol Oncol. 2007 Feb; 104(2 Suppl 1):13-6.
    View in: PubMed
    Score: 0.008
  75. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3.
    View in: PubMed
    Score: 0.008
  76. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol. 2006 Apr; 194(4):1186-93; discussion 1193-5.
    View in: PubMed
    Score: 0.007
  77. Fertility-sparing therapy for young women with endometrial cancer. Expert Rev Anticancer Ther. 2006 Jan; 6(1):27-32.
    View in: PubMed
    Score: 0.007
  78. Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract. Curr Oncol Rep. 2005 Nov; 7(6):435-43.
    View in: PubMed
    Score: 0.007
  79. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.
    View in: PubMed
    Score: 0.007
  80. Quality of life in cervix cancer survivors--what matters the most in the long-term? Gynecol Oncol. 2005 May; 97(2):307-9.
    View in: PubMed
    Score: 0.007
  81. Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma. Gynecol Oncol. 2005 Jun; 97(3):942-5.
    View in: PubMed
    Score: 0.007
  82. Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer. Int J Gynecol Cancer. 2024 Dec 02; 34(12):1861-1866.
    View in: PubMed
    Score: 0.007
  83. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004 Dec; 95(3):463-8.
    View in: PubMed
    Score: 0.007
  84. Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study. Gynecol Oncol. 2024 Dec; 191:143-149.
    View in: PubMed
    Score: 0.007
  85. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004 Sep; 199(3):388-93.
    View in: PubMed
    Score: 0.007
  86. Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol. 2004 Sep; 94(3):746-53.
    View in: PubMed
    Score: 0.007
  87. Innovations in Rare Gynecologic Cancer: Melanoma, Neuroendocrine, and Low-Grade Serous Ovarian. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e431818.
    View in: PubMed
    Score: 0.007
  88. LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. J Clin Oncol. 2024 Aug 10; 42(23):2741-2746.
    View in: PubMed
    Score: 0.007
  89. Consensus on surgical technique for sentinel lymph node dissection in cervical cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):504-509.
    View in: PubMed
    Score: 0.006
  90. Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study. Int J Gynecol Cancer. 2024 Feb 05; 34(2):209-215.
    View in: PubMed
    Score: 0.006
  91. Molecular image-guided surgery in gynaecological cancer: where do we stand? Eur J Nucl Med Mol Imaging. 2024 Aug; 51(10):3026-3039.
    View in: PubMed
    Score: 0.006
  92. Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors. Am J Obstet Gynecol. 2024 05; 230(5):544.e1-544.e13.
    View in: PubMed
    Score: 0.006
  93. Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical hysterectomy or trachelectomy. Int J Gynecol Cancer. 2024 Jan 05; 34(1):28-34.
    View in: PubMed
    Score: 0.006
  94. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
    View in: PubMed
    Score: 0.006
  95. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy. 2024 Jan-Feb; 23(1):1-9.
    View in: PubMed
    Score: 0.006
  96. Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. Endocr Relat Cancer. 2023 08 01; 30(8).
    View in: PubMed
    Score: 0.006
  97. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases. Am J Surg Pathol. 2023 06 01; 47(6):635-648.
    View in: PubMed
    Score: 0.006
  98. Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors. Am J Obstet Gynecol. 2023 06; 228(6):724.e1-724.e9.
    View in: PubMed
    Score: 0.006
  99. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. Int J Gynecol Cancer. 2023 02 06; 33(2):293-298.
    View in: PubMed
    Score: 0.006
  100. Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression. Gynecol Oncol. 2022 Dec; 167(3):483-489.
    View in: PubMed
    Score: 0.006
  101. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers. Curr Oncol Rep. 2022 11; 24(11):1521-1529.
    View in: PubMed
    Score: 0.006
  102. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal. Gynecol Oncol. 2022 06; 165(3):642-649.
    View in: PubMed
    Score: 0.006
  103. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365.
    View in: PubMed
    Score: 0.005
  104. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021 10; 31(10):1317-1325.
    View in: PubMed
    Score: 0.005
  105. Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer. Int J Gynecol Cancer. 2021 05; 31(5):647-655.
    View in: PubMed
    Score: 0.005
  106. Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer. 2021 03; 31(3):339-344.
    View in: PubMed
    Score: 0.005
  107. Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. 2020 07 01; 6(7):1019-1027.
    View in: PubMed
    Score: 0.005
  108. Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain. Int J Gynecol Cancer. 2020 06; 30(6):873-878.
    View in: PubMed
    Score: 0.005
  109. IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers. Int J Gynecol Cancer. 2020 05; 30(5):670-683.
    View in: PubMed
    Score: 0.005
  110. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers. Int J Gynecol Cancer. 2020 05; 30(5):561-563.
    View in: PubMed
    Score: 0.005
  111. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
    View in: PubMed
    Score: 0.005
  112. Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002). Gynecol Oncol. 2020 04; 157(1):161-166.
    View in: PubMed
    Score: 0.005
  113. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer. 2020 03; 30(3):352-357.
    View in: PubMed
    Score: 0.005
  114. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract. 2019 12; 15(12):e1092-e1097.
    View in: PubMed
    Score: 0.005
  115. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial. Am J Obstet Gynecol. 2020 03; 222(3):249.e1-249.e10.
    View in: PubMed
    Score: 0.005
  116. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer. 2019 10 01; 125(19):3347-3353.
    View in: PubMed
    Score: 0.005
  117. An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor. Gynecol Oncol. 2019 06; 153(3):541-548.
    View in: PubMed
    Score: 0.005
  118. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol. 2019 06; 135:58-64.
    View in: PubMed
    Score: 0.005
  119. Imaging and staging of neuroendocrine cervical cancer. Abdom Radiol (NY). 2018 12; 43(12):3468-3478.
    View in: PubMed
    Score: 0.004
  120. Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases. Gynecol Oncol. 2019 01; 152(1):101-105.
    View in: PubMed
    Score: 0.004
  121. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018 Nov 15; 379(20):1895-1904.
    View in: PubMed
    Score: 0.004
  122. PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer. Mol Cancer Ther. 2019 01; 18(1):162-172.
    View in: PubMed
    Score: 0.004
  123. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018; 9:2102.
    View in: PubMed
    Score: 0.004
  124. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol. 2018 11; 151(2):374-380.
    View in: PubMed
    Score: 0.004
  125. Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs. J Minim Invasive Gynecol. 2019 May - Jun; 26(4):727-732.
    View in: PubMed
    Score: 0.004
  126. Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (=2?cm) cervical cancer: Bridging the gap to fetal viability. Gynecol Oncol. 2018 07; 150(1):50-55.
    View in: PubMed
    Score: 0.004
  127. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol. 2018 Sep; 29(5):e68.
    View in: PubMed
    Score: 0.004
  128. Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete. Gynecol Oncol. 2018 06; 149(3):520-524.
    View in: PubMed
    Score: 0.004
  129. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018 03; 148(3):474-479.
    View in: PubMed
    Score: 0.004
  130. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018 01; 148(1):132-138.
    View in: PubMed
    Score: 0.004
  131. Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF). Gynecol Oncol. 2017 09; 146(3):676-677.
    View in: PubMed
    Score: 0.004
  132. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017 08; 146(2):234-239.
    View in: PubMed
    Score: 0.004
  133. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468.
    View in: PubMed
    Score: 0.004
  134. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104.
    View in: PubMed
    Score: 0.004
  135. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553.
    View in: PubMed
    Score: 0.004
  136. Utility of indocyanine green (ICG) intra-operative angiography to determine uterine vascular perfusion at the time of radical trachelectomy. Gynecol Oncol. 2016 Nov; 143(2):357-361.
    View in: PubMed
    Score: 0.004
  137. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard? J Minim Invasive Gynecol. 2016 Feb 01; 23(2):186-93.
    View in: PubMed
    Score: 0.004
  138. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer. 2015 Oct; 25(8):1437-44.
    View in: PubMed
    Score: 0.004
  139. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer. Int J Gynecol Cancer. 2015 Sep; 25(7):1292-9.
    View in: PubMed
    Score: 0.004
  140. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016 Apr; 10(2):261-70.
    View in: PubMed
    Score: 0.004
  141. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. 2016 Feb; 43(2):316-24.
    View in: PubMed
    Score: 0.004
  142. Is it equivalent? Evaluation of the clinical activity of single agent Lipodox? compared to single agent Doxil? in ovarian cancer treatment. J Oncol Pharm Pract. 2016 Aug; 22(4):599-604.
    View in: PubMed
    Score: 0.004
  143. Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology. Int J Gynecol Cancer. 2015 Jul; 25(6):1121-7.
    View in: PubMed
    Score: 0.004
  144. Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs. Int J Gynecol Cancer. 2015 Jul; 25(6):1115-20.
    View in: PubMed
    Score: 0.004
  145. Overview of the Role of Imaging in Pelvic Exenteration. Radiographics. 2015 Jul-Aug; 35(4):1286-94.
    View in: PubMed
    Score: 0.004
  146. Radical trachelectomy in early-stage cervical cancer: A comparison of laparotomy and minimally invasive surgery. Gynecol Oncol. 2015 Sep; 138(3):585-9.
    View in: PubMed
    Score: 0.004
  147. Radical Trachelectomy for Early-Stage Cervical Cancer: A Survey of the Society of Gynecologic Oncology and Gynecologic Oncology Fellows-in-Training. Int J Gynecol Cancer. 2015 May; 25(4):681-7.
    View in: PubMed
    Score: 0.003
  148. Targeting those with decreased meaning and peace: a supportive care opportunity. Support Care Cancer. 2015 Jul; 23(7):2025-32.
    View in: PubMed
    Score: 0.003
  149. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol. 2015 Feb; 136(2):269-73.
    View in: PubMed
    Score: 0.003
  150. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol. 2015 Jan; 136(1):48-53.
    View in: PubMed
    Score: 0.003
  151. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014 Sep; 134(3):546-51.
    View in: PubMed
    Score: 0.003
  152. Patient preferences for side effects associated with cervical cancer treatment. Int J Gynecol Cancer. 2014 Jul; 24(6):1077-84.
    View in: PubMed
    Score: 0.003
  153. Summary of the 2014 MD Anderson International Meeting in Gynecologic Oncology: emerging therapies in gynecologic cancer. Gynecol Oncol. 2014 Jul; 134(1):6-9.
    View in: PubMed
    Score: 0.003
  154. Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes? Gynecol Oncol. 2014 Aug; 134(2):248-52.
    View in: PubMed
    Score: 0.003
  155. Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation. AJR Am J Roentgenol. 2014 Jun; 202(6):1171-8.
    View in: PubMed
    Score: 0.003
  156. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol. 2014 Feb; 132(2):366-71.
    View in: PubMed
    Score: 0.003
  157. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol. 2014 Jan; 132(1):114-8.
    View in: PubMed
    Score: 0.003
  158. Targeting SRC and tubulin in mucinous ovarian carcinoma. Clin Cancer Res. 2013 Dec 01; 19(23):6532-43.
    View in: PubMed
    Score: 0.003
  159. Successful incorporation of robotic surgery into gynecologic oncology fellowship training. Gynecol Oncol. 2013 Dec; 131(3):730-3.
    View in: PubMed
    Score: 0.003
  160. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014 Jan; 132(1):254-9.
    View in: PubMed
    Score: 0.003
  161. Venous thromboembolic events in minimally invasive gynecologic surgery. J Minim Invasive Gynecol. 2013 Nov-Dec; 20(6):766-9.
    View in: PubMed
    Score: 0.003
  162. We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4.
    View in: PubMed
    Score: 0.003
  163. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol. 2013 Jun; 129(3):513-6.
    View in: PubMed
    Score: 0.003
  164. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2013 Jun; 129(3):580-5.
    View in: PubMed
    Score: 0.003
  165. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol. 2013 Feb; 128(2):204-8.
    View in: PubMed
    Score: 0.003
  166. Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: a comparison between laparoscopy and robotic surgery. Ann Surg Oncol. 2013 Apr; 20(4):1355-9.
    View in: PubMed
    Score: 0.003
  167. Laparoscopic radical trachelectomy. JSLS. 2012 Jul-Sep; 16(3):503-7.
    View in: PubMed
    Score: 0.003
  168. Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gynecol Oncol. 2012 Sep; 126(3):428-31.
    View in: PubMed
    Score: 0.003
  169. Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Jun; 125(3):556-60.
    View in: PubMed
    Score: 0.003
  170. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol. 2012 May; 125(2):336-42.
    View in: PubMed
    Score: 0.003
  171. Quality of laparoscopic radical hysterectomy in developing countries: a comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia. Gynecol Oncol. 2012 May; 125(2):326-9.
    View in: PubMed
    Score: 0.003
  172. Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecol Oncol. 2012 Apr; 125(1):241-4.
    View in: PubMed
    Score: 0.003
  173. Proceedings from the 9th International Conference on Ovarian Cancer. Gynecol Oncol. 2012 Apr; 125(1):5-7.
    View in: PubMed
    Score: 0.003
  174. Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: an analysis of surgical outcomes. Gynecol Oncol. 2012 Apr; 125(1):252-5.
    View in: PubMed
    Score: 0.003
  175. Comparison of single-port laparoscopy, standard laparoscopy, and robotic surgery in patients with endometrial cancer. Ann Surg Oncol. 2012 May; 19(5):1583-8.
    View in: PubMed
    Score: 0.003
  176. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol. 2012 Feb; 124(2):180-4.
    View in: PubMed
    Score: 0.003
  177. Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gynecol Oncol. 2012 Feb; 124(2):276-80.
    View in: PubMed
    Score: 0.003
  178. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.
    View in: PubMed
    Score: 0.003
  179. Targeting SRC in mucinous ovarian carcinoma. Clin Cancer Res. 2011 Aug 15; 17(16):5367-78.
    View in: PubMed
    Score: 0.003
  180. Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies. Int J Gynecol Cancer. 2011 Jul; 21(5):936-40.
    View in: PubMed
    Score: 0.003
  181. Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 2011 Mar; 120(3):321-5.
    View in: PubMed
    Score: 0.003
  182. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer. 2011 May 01; 117(9):1928-34.
    View in: PubMed
    Score: 0.003
  183. Limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy. Int J Gynecol Cancer. 2010 Nov; 20(8):1344-9.
    View in: PubMed
    Score: 0.003
  184. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol. 2010 Oct; 116(4):956-961.
    View in: PubMed
    Score: 0.003
  185. Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol. 2011 Jan; 120(1):47-51.
    View in: PubMed
    Score: 0.003
  186. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2010 Dec; 119(3):422-5.
    View in: PubMed
    Score: 0.003
  187. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010 Nov; 119(2):291-4.
    View in: PubMed
    Score: 0.003
  188. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Gynecol Oncol. 2010 Nov; 119(2):183-6.
    View in: PubMed
    Score: 0.003
  189. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol. 2010 Aug; 116(2 Pt 1):269-273.
    View in: PubMed
    Score: 0.003
  190. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.
    View in: PubMed
    Score: 0.002
  191. Microscopic evaluation of lymph-node-bearing tissue in early-stage cervical cancer: a dual-institution review. Ann Surg Oncol. 2010 Apr; 17(4):1106-10.
    View in: PubMed
    Score: 0.002
  192. Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med. 2009 Dec; 34(12):859-61.
    View in: PubMed
    Score: 0.002
  193. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? Am J Surg Pathol. 2009 Feb; 33(2):298-303.
    View in: PubMed
    Score: 0.002
  194. Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update. Gynecol Oncol. 2009 Mar; 112(3):501-5.
    View in: PubMed
    Score: 0.002
  195. Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer. Gynecol Oncol. 2009 Jan; 112(1):110-3.
    View in: PubMed
    Score: 0.002
  196. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol. 2008 Sep; 32(9):1336-43.
    View in: PubMed
    Score: 0.002
  197. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.
    View in: PubMed
    Score: 0.002
  198. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol. 2007 Dec; 107(3):458-63.
    View in: PubMed
    Score: 0.002
  199. Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol. 2007 Jul; 106(1):12-5.
    View in: PubMed
    Score: 0.002
  200. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol. 2007 May; 105(2):304-11.
    View in: PubMed
    Score: 0.002
  201. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.
    View in: PubMed
    Score: 0.002
  202. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 2006 Jun 01; 106(11):2452-8.
    View in: PubMed
    Score: 0.002
  203. Current perspectives on lymphatic mapping in carcinomas of the uterine corpus and cervix. J Natl Compr Canc Netw. 2006 May; 4(5):471-8.
    View in: PubMed
    Score: 0.002
  204. Are women ready for the HPV vaccine? Gynecol Oncol. 2006 Oct; 103(1):151-4.
    View in: PubMed
    Score: 0.002
  205. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol. 2006 Sep; 102(3):534-6.
    View in: PubMed
    Score: 0.002
  206. Quality of life and gynecologic malignancies. Curr Oncol Rep. 2005 Nov; 7(6):459-65.
    View in: PubMed
    Score: 0.002
  207. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res. 2005 Sep 01; 11(17):6116-26.
    View in: PubMed
    Score: 0.002
  208. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005 Jul; 98(1):161-7.
    View in: PubMed
    Score: 0.002
  209. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004 Oct; 95(1):133-8.
    View in: PubMed
    Score: 0.002
  210. Recruitment and screening policies and procedures used to establish a paid donor oocyte registry. Hum Reprod. 1998 Jul; 13(7):2020-4.
    View in: PubMed
    Score: 0.001
  211. The beta-core fragment of chorionic gonadotropin is not complexed to macromolecules in amniotic fluid. J Clin Endocrinol Metab. 1994 Jun; 78(6):1349-53.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.